MKI67 and breast carcinoma: Ki-67 is expressed in all active phases of the cell cycle (G1, S, G2, M), but is absent in resting cells (G0), and has been established as a prognostic tool predicting relapse-free and overall survival in breast cancer patients [52,53,54].